List of Zoladex drug patents
Zoladex is owned by Tersera.
Zoladex contains Goserelin Acetate.
Zoladex has a total of 2 drug patents out of which 2 drug patents have expired.
Expired drug patents of Zoladex are:
- US7220247
- US7118552
Zoladex was authorised for market use on 29 December, 1989.
Zoladex is available in implant;implantation dosage forms.
The generics of Zoladex are possible to be released after 13 April, 2022.
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US7220247 | TERSERA | Automatically operable safety shield system for syringes |
Apr, 2022
(11 months ago) | |
| US7118552 | TERSERA | Automatically operable safety shield system for syringes |
Apr, 2022
(11 months ago) | |
Drugs and Companies using GOSERELIN ACETATE ingredient
Market Authorisation Date: 29 December, 1989
Treatment: NA
Dosage: IMPLANT;IMPLANTATION
ZOLADEX family patents
4
Japan
3
United States
2
United Kingdom
1
Portugal
1
Germany
1
Malaysia
1
Russia
1
Spain
1
Brazil
1
Colombia
1
New Zealand
1
Estonia
1
Norway
1
Argentina
1
Austria
1
Mexico
1
China
1
Taiwan, Province of China
1
Korea, Republic of
1
Hong Kong
1
South Africa
1
Slovakia
1
Canada
1
Cyprus
1
Slovenia
1
Bulgaria
1
Hungary
1
Ukraine
1
Czech Republic
1
Israel
1
Iceland
1
Poland
1
Australia
1
Denmark
1
European Union
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic